Skip to main content
Log in

Effect of central administration of the neurotrophic factors BDNF and GDNF on the functional activity and expression of 5-HT2A serotonin receptors in mice genetically predisposed to depressive-like behavior

  • Cell Molecular Biology
  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

The brain’s serotonin (5-HT) system plays an important role in the control of normal and pathological behavior. 5-HT2A receptors are widely implicated in the regulation of normal brain functions and in the pathogenesis of mental disorders, especially schizophrenia and depression. In this work, we studied the involvement of 5-HT2A receptors in the action of the brain-derived neurotrophic factor (BDNF) and the glial cell line-derived neurotrophic factor (GDNF). It was found that an acute intracerebroventricular BDNF injection caused a considerable increase in the functional activity of 5-HT2A receptors in ASC mice genetically predisposed to depression-like behavior. Moreover, as a result of the administration of BDNF, the expression of the 5-HT2A receptor gene increased in the hippocampus, decreased in the frontal cortex, and did not change in the midbrain. In contrast, GDNF administration did not affect the functional activity of 5-HT2A receptors, but increased the expression of the 5-HT2A receptor gene in the frontal cortex, but not in the hippocampus or the midbrain. Thus, the central administration of BDNF and GDNF was shown to affect the functional activity of 5-HT2A receptors and the expression of their genes. These results indicate that 5-HT2A receptors can be involved in the mechanisms of BDNF and GDNF action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

5-HT:

serotonin

5-HT2A :

receptor, subtype 2A serotonin receptor

BDNF:

brain-derived neurotrophic factor

GDNF:

glial cell line-derived neurotrophic factor

FGFR:

fibroblast growth factor receptor

Polr2a :

DNA-directed RNA polymerase II gene

Gapdh :

glyceraldehyde-3-phosphate dehydrogenase gene

RT:

reverse transcription

PCR:

polymerase chain reaction

FST:

forced swim test

References

  1. Popova N.K., Naumenko E.V., Kolpakov V.G. 1978. Serotonin i povedenie (Serotonin and Behavior), Novosibirsk: Nauka.

    Google Scholar 

  2. Lucki I. 1998. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry. 44, 151–162.

    Article  CAS  PubMed  Google Scholar 

  3. Hannon J., Hoyer D. 2008. Molecular biology of 5-HT receptors. Behav. Brain. Res. 195, 198–213.

    Article  CAS  PubMed  Google Scholar 

  4. Dean B. 2003. The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice. J. Neurochem. 85, 1–13.

    Article  CAS  PubMed  Google Scholar 

  5. Mintun M.A., Sheline Y.I., Moerlein S.M., Vlassenko A.G., Huang Y., Snyder A.Z. 2004. Decreased hippocampal 5-HT2A receptorbinding in major depressive disorder: In vivo measurement with [18F]altanserin positron emission tomography. Biol. Psychiatry. 55, 217–224.

    Article  CAS  PubMed  Google Scholar 

  6. Alex K.D., Pehek E.A. 2007. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol. Ther. 113, 296–320.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Deltheil T., Guiard B.P., Cerdan J., David D.J., Tanaka K.F., Reperant C., Guilloux J.P., Coudore F., Hen R., Gardier A.M. 2008. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology. 55, 1006–1014.

    Article  CAS  PubMed  Google Scholar 

  8. Duman R.S. 2009. Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues Clin. Neurosci. 11, 239–255.

    PubMed Central  PubMed  Google Scholar 

  9. Rangasamy S.B., Soderstrom K., Bakay R.A., Kordower J.H. 2010. Neurotrophic factor therapy for Parkinson’s disease. Prog. Brain. Res. 184, 237–264.

    Article  CAS  PubMed  Google Scholar 

  10. Hoshaw B.A., Malberg J.E., Lucki I. 2005. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 1037, 204–208.

    Article  CAS  PubMed  Google Scholar 

  11. Hisaoka K., Nishida A., Takebayashi M., Koda T., Yamawaki S., Nakata Y. 2004. Serotonin increases glial cell line-derived neurotrophic factor release in rat C6 glioblastoma cells. Brain Res. 1002, 167–170.

    Article  CAS  PubMed  Google Scholar 

  12. Tsuchioka M., Takebayashi M., Hisaoka K., Maeda N., Nakata Y. 2008. Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells. J. Neurochem. 106, 244–257.

    Article  CAS  PubMed  Google Scholar 

  13. Zhang X., Zhang Z., Xie C., Xi G., Zhou H., Zhang Y., Sha W. 2008. Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry. 32, 886–890.

    Article  CAS  PubMed  Google Scholar 

  14. Diniz B.S., Teixeira A.L., Miranda A.S., Talib L.L., Gattaz W.F., Forlenza O.V. 2012. Circulating glial-derived neurotrophic factor is reduced in late-life depression. J. Psychiatr. Res. 46, 135–139.

    Article  PubMed  Google Scholar 

  15. Vaidya V.A., Marek G.J., Aghajanian G.K., Duman R.S. 1997. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. 17, 2785–2795.

    CAS  PubMed  Google Scholar 

  16. Meller R., Babity J.M., Grahame-Smith D.G. 2002. 5-HT2A receptor activation leads to increased BDNF mRNA expression in C6 glioma cells. Neuromol. Med. 1, 197–205.

    Article  CAS  Google Scholar 

  17. Tan Q.R., Wang X.Z., Wang C.Y., Liu X.J., Chen Y.C., Wang H.H., Zhang R.G., Zhen X.C., Tong Y., Zhang Z.J. 2007. Differential effects of classical and atypical antipsychotic drugs on rotenone-induced neurotoxicity in PC12 cells. Eur. Neuropsychopharmacol. 17, 768–773.

    Article  CAS  PubMed  Google Scholar 

  18. Kulikov A.V., Bazovkina D.V., Kondaurova E.M., Popova N.K. 2008. Genetic structure of hereditary catalepsy in mice. Genes Brain Behav. 7, 506–512.

    Article  CAS  PubMed  Google Scholar 

  19. Slotnick B.M., Leonard C.M. 1975. A Stereotaxic Atlas of the Albino Mouse Forebrain. Rockville, MD: U.S. Dept. Health, Education and Welfare.

    Google Scholar 

  20. Green A.R., Heal D.J. 1985. The effects of drugs on serotonin-mediated behavioural models. In: Neuropharmacology of Serotonin. Ed. Green A.R. Oxford: Oxford Univ. Press, pp. 326–365.

    Google Scholar 

  21. Naumenko V.S., Kulikov A.V. 2006. Quantitative assay of 5-HT(1A) serotonin receptor gene expression in the brain. Mol. Biol. (Moscow). 40, 30–36.

    Article  CAS  Google Scholar 

  22. Moisan M.-P., Courvoisier H., Bihoreau M.-T., Gauguier D., Hendley E.D., Lathrop M., James M.R. Mormede P. 1996. A major quantitative trait locus influences hyperactivity in the WKHA rat. Nature Genet. 14, 471–473.

    Article  CAS  PubMed  Google Scholar 

  23. Siuciak J.A., Lewis D.R. Wiegand S.J., and Lindsay R.M. 1997. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56, 131–137.

    Article  CAS  PubMed  Google Scholar 

  24. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. 2002. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22, 3251–3261.

    CAS  PubMed  Google Scholar 

  25. Zanardi R., Artigas F., Moresco R., Colombo C., Messa C., Gobbo C., Smeraldi E., Fazio F. 2001. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. J. Clin. Psychopharmacol. 21, 53–58.

    Article  CAS  PubMed  Google Scholar 

  26. Bach H., Arango V. 2012. Neuroanatomy of serotonergic abnormalities in suicide. In: The Neurobiological Basis of Suicide. Ed. Dwivedi Y. Boca Raton, FL: CRC Press, pp. 11–29.

    Chapter  Google Scholar 

  27. Nemeroff C.B. 2005. Use of atypical antipsychotics in refractory depression and anxiety. J. Clin. Psychiatry. 66, 13–21.

    CAS  PubMed  Google Scholar 

  28. Semenova A.A., Bazovkina D.V., Tsybko A.S., Naumenko V.S., Popova N.K. 2013. Effect of GDNF on the behavior of ASC mice with high hereditary predisposition to catalepsy. Zh. Vyssh. Nerv. Deyat. 63, 495–501.

    CAS  Google Scholar 

  29. Pascual A., Hidalgo-Figueroa M., Gómez-Díaz R., López-Barneo J. 2011. GDNF and protection of adult central catecholaminergic neurons. J. Mol. Endocrinol. 46, 83–92.

    Article  Google Scholar 

  30. Klein A.B., Santini M.A., Aznar S., Knudsen G.M., Rios M. 2010. Changes in 5-HT2A-mediated behavior and 5-HT2A- and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knockout mice. Neuroscience. 169, 1007–1016.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. S. Tsybko.

Additional information

Original Russian Text © A.S. Tsybko, T.V. Il’chibaeva, E.M. Kondaurova, D.V. Bazovkina, V.S. Naumenko, 2014, published in Molekulyarnaya Biologiya, 2014, Vol. 48, No. 6, pp. 983–989.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsybko, A.S., Il’chibaeva, T.V., Kondaurova, E.M. et al. Effect of central administration of the neurotrophic factors BDNF and GDNF on the functional activity and expression of 5-HT2A serotonin receptors in mice genetically predisposed to depressive-like behavior. Mol Biol 48, 864–869 (2014). https://doi.org/10.1134/S0026893314060181

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026893314060181

Keywords

Navigation